Faculty profile
Jillian Kohler
Back to facultyResearch
Read how they describe their research on their University of Toronto profile.
Latest papers
Institutional factors influencing vaccine access in Canada: a scoping review.
BMC public health · 2026 · senior author
Patient organizations involvement in healthcare: a rapid review and conceptual framework.
Globalization and health · 2026 · senior author
Bribery and the Global Pharmaceutical Industry: An Exploration of Patterns and Penalties in the Organisation for Economic Cooperation and Development Reports.
The Journal of law, medicine & ethics : a journal of the American Society of Law, Medicine & Ethics · 2026 · first author
Latest funding
- $3,934,956
MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine - from research to patient care to global impact.
SSHRC · 2024 · Co-investigator
- $75,000
Corruption Risks in the Global Deployment of COVID-19 Vaccines: The Case of COVAX
SSHRC · 2021 · Principal investigator
- $210,945
Evaluating Accountability, Transparency and Governance in Brazil's Pharmaceutical System
CIHR · 2012 · Nominated PI
15 publications.
Institutional factors influencing vaccine access in Canada: a scoping review.
Rahman S, Zhang C, Khan A, Bowra A, Adanty C, Villa DS, Maor G, Scarfone K, Kohler J
Patient organizations involvement in healthcare: a rapid review and conceptual framework.
Gentilini A, Parvanova I, Ghazi S, Scarfone KM, Kohler J
Bribery and the Global Pharmaceutical Industry: An Exploration of Patterns and Penalties in the Organisation for Economic Cooperation and Development Reports.
Kohler J, Khan A, Bowra A
Evaluating the corporate social responsibility agenda for high-cost novel therapies: roles for government and civil society.
Wong A, Saeed G, Garner S, Kohler J
Good governance essential to expanding vaccine capacity and strengthening public trust.
Lee K, Kohler J
Corruption risks in health procurement during the COVID-19 pandemic and anti-corruption, transparency and accountability (ACTA) mechanisms to reduce these risks: a rapid review.
Griffore KA, Bowra A, Guilcher SJT, Kohler J
Examining corruption risks in the procurement and distribution of COVID-19 vaccines in select states in Nigeria.
Onwujekwe O, Orjiakor C, Ogbozor P, Agu I, Agwu P, Wright T, Balabanova D, Kohler J
Anti-corruption in global health systems: using key informant interviews to explore anti-corruption, accountability and transparency in international health organisations.
Gorodensky A, Bowra A, Saeed G, Kohler J
Improving Access to COVID-19 Vaccines: An Analysis of TRIPS Waiver Discourse among WTO Members, Civil Society Organizations, and Pharmaceutical Industry Stakeholders.
Kohler J, Wong A, Tailor L
A global social contract to ensure access to essential medicines and health technologies.
Perehudoff K, Wirtz VJ, Wong A, Rusu V, Kohler J
MitoRevolution: Mitochondrial Transplantation Transforming Regenerative Medicine - from research to patient care to global impact.
Principal investigators: Andreazza, Ana
Corruption Risks in the Global Deployment of COVID-19 Vaccines: The Case of COVAX
Principal investigators: Kohler, Jillian
Keywords: COVID-19; Equity; Access to Vaccines; Transparency; Accountability; Good Governance; COVAX Facility; Global Health; Anti-corruption
Evaluating Accountability, Transparency and Governance in Brazil's Pharmaceutical System
Principal investigators: Kohler, Jillian
Keywords: Brazil; Global Health; Governance; Health Equity; Pharmaceutical Policy
Assessing the Ethics of the Dominant Business Model in the Canadian Pharmaceutical Sector; Tackling Institutional Corruption through Regulatory Reforms
Principal investigators: Gagnon, Marc-André
Keywords: Business Model; Cost And Prices Of Medicines; Ghostmanagement Of Medical Literature; Innovation Policies; Investment And Profitability; Off-Label Use; Pharmaceutical Promotion; Pharmaceutical Sector; Research Ethics; Therapeutic Innovation
Exploring cultures of medicines-related health care decision-making by elderly women and men
Principal investigators: Ballantyne, Peri J.
Keywords: elderly; medicines; decision-making; compliance/adherence; patient/professional relations
From CIHR, NSERC and SSHRC funding decisions: CIHR since 2008, NSERC since 1991 and SSHRC since 1998, including their latest published competition results.
Frequent collaborators
- Jillian Kohler and Kelley Lee: 1 shared paper
- Jillian Kohler and Lisa Forman: 1 shared paper
- Jillian Kohler and Quinn Grundy: 1 shared paper
- Social & Behavioural Health Sciences Division
- Dalla Lana School of Public Health
- Education
- Other
Co-authors at University of Toronto, colored by department. Thicker lines mean more shared papers; select anyone to open their profile and their own map.
A short, specific email works best. This draft uses one of their recent papers; replace the parts in brackets with your own details before sending.
Profile data last refreshed on September 25, 2026 from the university directory, publication records and CIHR, NSERC and SSHRC funding.